Articles
A Collaborative Effort Paves the Way for a New Approach to Small Batch Manufacturing
In today’s pharmaceutical industry there is a sharp focus on the needs and requirements of the patient. More and more drugs are being developed...
News
Saphnelo approved in Japan for systemic lupus erythematosus
AstraZeneca’s Saphnelo (anifrolumab) has been approved in Japan for the treatment of adult patients with systemic lupus erythematosus (SLE), a serious autoimmune disease, who...
Drug Research
Sanofi to focus its COVID-19 development efforts on the recombinant vaccine candidate
Recent positive interim results of Sanofi’s mRNA-based COVID-19 vaccine candidate Phase 1/2 study confirm the company’s platform robust capabilities and strategy in mRNA.
Taking into...
Drug Research
Syndax and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases
Syndax Pharmaceuticals, Inc. and Incyte announced that they have entered into an exclusive worldwide collaboration and license agreement to develop and commercialize axatilimab, Syndax’s...
Drug Research
Union therapeutics signs deal with Innovent to develop orismilast in China
Union therapeutics has signed a strategic partnership and license agreement with Innovent Biologics to develop and commercialise its therapy, orismilast, in China.
A potent and...
Press Releases
Envigo announces collaboration with Biocytogen to distribute the B-NDG triple immunodeficient and humanizable mouse mode
Envigo RMS Holding Corp. announces a collaboration with Biocytogen, a global biotech company that drives the research and development of new drugs with innovative...
News
Paradigm4 launches flexFS for high throughput and resource efficient management for life science and healthcare data in the cloud
Paradigm4, an integrated scientific data analytics company, has launched flexFS TM , its innovative, elastic cloud file system for flexible and more resource efficient...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read